Tuhura Biosciences, Inc/nv DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
TuHURA Biosciences announces its 2026 Annual Meeting of Stockholders to be held virtually on August 18, 2026, with key proposals including director elections, stock issuance approval, and executive compensation votes.
NASDAQ
Kintara Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on June 20, 2024, to vote on director elections, executive compensation, and auditor ratification.